Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | PPARD | Q03181 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11308525 | 0.82 | TSHR (0.43) | TSHRTP53TDP1PPARD | |
| SCHEMBL28008094 | 0.78 | MEN1 (0.39) | TSHRTP53TDP1PPARDMEN1 | |
| SCHEMBL524900 | 0.78 | PPARD (0.58) | TSHRTP53TDP1PPARDALDH1A1 | |
| SCHEMBL5664469 | 0.78 | TSHR (0.48) | TSHRTP53TDP1PPARDMEN1 | |
| SCHEMBL10481895 | 0.76 | TSHR (0.75) | TSHRTP53TDP1PPARDMEN1 | |
| SCHEMBL4060148 | 0.76 | TSHR (0.52) | TSHRTP53TDP1PPARDMEN1 | |
| SCHEMBL3313657 | 0.75 | PPARD (0.70) | TSHRTP53TDP1PPARDMEN1 | |
| SCHEMBL5961215 | 0.75 | TSHR (1.00) | TSHRTP53TDP1PPARDMEN1 | |
| SCHEMBL282472 | 0.75 | TSHR (0.67) | TSHRTP53TDP1PPARDMEN1 | |
| SCHEMBL26483 | 0.75 | TSHR (1.00) | TSHRTP53TDP1PPARDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118813195-A | Environment-friendly weather-resistant flame-retardant adhesive and preparation method and application thereof | 李水永 | 2024-10-22 | — | — | CN | claimed |
| CN-118507986-A | High-thermal-stability battery diaphragm and preparation method thereof | 湖南博盛新能源技术有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-118271578-A | Polymer with phosphonic acid structure in side chain, synthesis method and application thereof in high-temperature proton exchange membrane fuel cell | 中国科学院山西煤炭化学研究所 | 2024-07-02 | — | — | CN | claimed |
| CN-116922881-A | Thermal insulation composite board and preparation method thereof | 安徽宏志建材科技有限公司 | 2023-10-24 | — | — | CN | claimed |
| CN-111187325-A | Anti-tumor (4' R) -methyl- α -L-ribofuranose nucleoside and preparation method thereof | 郑州大学 | 2020-05-22 | — | — | CN | claimed |
| CN-103664960-B | Pu Na is for the preparation method of Buddhist nun | SUZHOU MINGYUE MEDICAL TECHNOLOGY CO., LTD. (CN) | 2015-08-05 | — | — | CN | claimed |
| CN-103664960-A | Preparation method for Ponatinib | SUZHOU MIRACPHARMA TECHNOLOGY CO LTD | 2014-03-26 | — | — | CN | claimed |
| EP-3801553-B1 | PRODRUGS OF FULVESTRANT | KASHIV BIOSCIENCES LLC (US) | 2026-03-25 | — | — | EP | disclosed |
| US-20250298333-A1 | POLYESTER RESIN COMPOSITION, ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, DEVELOPER, AND IMAGE FORMING METHOD | Konica Minolta, Inc. (JP) | 2025-09-25 | — | — | US | disclosed |
| US-20250281519-A1 | NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS, COMBINATIONS AND USES RELATED THERETO | EMORY UNIVERSITY | 2025-09-11 | — | — | US | disclosed |
| CN-119751939-A | Waterproof PET film for photovoltaic backboard and preparation method thereof | 浙江大东南股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-118813195-A | Environment-friendly weather-resistant flame-retardant adhesive and preparation method and application thereof | 李水永 | 2024-10-22 | — | — | CN | disclosed |
| CN-118507986-B | High-thermal-stability battery diaphragm and preparation method thereof | 湖南博盛新能源技术有限公司 | 2024-09-24 | — | — | CN | disclosed |
| EP-0224209-A2 | Process for recovery of rare metals | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-06-03 | — | — | EP | disclosed |
| EP-0204217-A1 | Recovery of metals adsorbed on chelating agents | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-12-10 | — | — | EP | disclosed |
| EP-0190676-A1 | Cis-1,3,5-triamino 2,4,6-cyclohexanetriol derivatives, their use, process for their preparation and pharmaceutical preparations containing them | Laboratorien Hausmann AG (CH) | 1986-08-13 | — | — | EP | disclosed |
| US-4565673-A | USING A HALOGEN-FREE ACID FOLLOWED BY A HALOGEN-CONTAINING SOLUTION FOR SELECTIVE SEPARATION FROM OTHER METALS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-01-21 | — | — | US | disclosed |
| EP-0148158-A2 | Process for eluting indium from a chelate resin containing adsorbed indium | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-07-10 | — | — | EP | disclosed |
| US-4141734-A | SUBSTITUTED ORGANIC DI- OR TRISULFIDE ANTIDEPOSIT AGENTS | CIBA-GEIBY AG (CH) | 1979-02-27 | — | — | US | disclosed |
| US-4092108-A | AMINE SUBSTITUTED PHOSPHONIC ACID DERIVATIVES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1978-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250281519-A1 | NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS, COMBINATIONS AND USES RELATED THERETO | NTPCR, TYMP, MTAP | TSHR 3042/4885TP53 602/4885TDP1 369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.